Showing 1 - 10 of 2,682
We analyze the financial performance of a hypothetical portfolio of 120 mRNA vaccine candidates in the preclinical stage targeting 11 emerging infectious diseases. We calibrate the simulation parameters with input from domain experts in mRNA technology and an extensive literature review. We find...
Persistent link: https://www.econbiz.de/10013334345
Persistent link: https://www.econbiz.de/10000882071
Persistent link: https://www.econbiz.de/10000883027
Persistent link: https://www.econbiz.de/10000885516
Persistent link: https://www.econbiz.de/10000886687
Persistent link: https://www.econbiz.de/10000886959
Persistent link: https://www.econbiz.de/10000888096
Persistent link: https://www.econbiz.de/10000889938
Persistent link: https://www.econbiz.de/10000890492
Persistent link: https://www.econbiz.de/10000892867